Skip to content

Clinical trials

Phase 2/3 Carcinoma, Non-Small-Cell Lung trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2/3 Status: Unknown status Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20091
20101
20111
20131
20142
20151
20162
20172
20212
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biocad1
Chang Gung Memorial Hospital1
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1
Genta Incorporated1
Guangdong Association of Clinical Trials1
Guangdong Provincial People's Hospital1
Il Yeong Park, Ph.D.1
Instituto Nacional de Cancerologia de Mexico1
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd1
People's Hospital of Guangxi Zhuang Autonomous Region1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung16
Lung Neoplasms4
Anorexia1
Brain Neoplasms1
Breast Neoplasms1
Cachexia1
Prostatic Neoplasms1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.